KS

Kedarmal Shankarlal Bankda

Active Director Director DIN 00023050
DIN 00023050 First appointment Apr 1992 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Apr 1992
Shareholding value •••• Premium profile

About Kedarmal Shankarlal Bankda

Data last updated:

Kedarmal Shankarlal Bankda is a Director at Vincit Biotech International Private Limited (since 2022), Director at Synmex Pharma Private Limited (since 2022) and Whole-Time Director at Syncom Formulations (India) Limited (since 1992), and holds 1 more current directorship. The companies operate in Pharma and Trading. The 4 current companies with reported revenue have a combined latest revenue of ₹26.12 Cr; the largest is Vincit Biotech International Private Limited at ₹13.14 Cr (FY 2025). Earlier, Kedarmal Shankarlal Bankda was a Director at Arp Pharma Private Limited (from 2008).

DIN 00023050
Primary Designation Director
Industry Pharma
First Appointment 13 Apr 1992
Oldest Company Age 38 yrs
Largest company Vincit Biotech International Private Limited · ₹13.14 Cr (FY 2025)
Combined revenue ₹26.12 Cr across 4 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director25 Jul 20222022₹13.14 Cr (FY 2025)Active
Synmex Pharma Private Limited U51909MP2022PTC061919
Director21 Jul 20222022₹7.09 Cr (FY 2025)Active
Syncom Formulations (India) Limited L24239MH1988PLC047759
Whole-Time Director13 Apr 19921988₹5.88 Cr (FY 2025)Active
Sante Biotech Private Limited U51909MP2022PTC061915
Director21 Jul 20222022₹1.5 Lakh (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arp Pharma Private Limited U24232MP1996PTC011159
Director30 Aug 20081996Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arp Pharma Private Limited
Sante Biotech Private Limited
Synmex Pharma Private Limited
Vincit Biotech International Private Limited
Premium access

Shareholding and investment profile for Kedarmal Shankarlal Bankda

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kedarmal Shankarlal Bankda

Kedarmal Shankarlal Bankda currently holds 4 directorships: Vincit Biotech International Private Limited (Director, since 25 Jul 2022, revenue ₹13.14 Cr (FY 2025)); Synmex Pharma Private Limited (Director, since 21 Jul 2022, revenue ₹7.09 Cr (FY 2025)); Syncom Formulations (India) Limited (Whole-Time Director, since 13 Apr 1992, revenue ₹5.88 Cr (FY 2025)); Sante Biotech Private Limited (Director, since 21 Jul 2022, revenue ₹1.5 Lakh (FY 2025)).

Kedarmal Shankarlal Bankda was first appointed on 13 Apr 1992 as Whole-Time Director at Syncom Formulations (India) Limited. The most recent appointment on record is 25 Jul 2022 at Vincit Biotech International Private Limited.

The 4 current companies of Kedarmal Shankarlal Bankda that report revenue have a combined latest revenue of ₹26.12 Cr: Vincit Biotech International Private Limited ₹13.14 Cr (FY 2025); Synmex Pharma Private Limited ₹7.09 Cr (FY 2025); Syncom Formulations (India) Limited ₹5.88 Cr (FY 2025); Sante Biotech Private Limited ₹1.5 Lakh (FY 2025).

Kedarmal Shankarlal Bankda held 1 earlier board appointment: Arp Pharma Private Limited (Director, from 30 Aug 2008).

The current boards of Kedarmal Shankarlal Bankda's companies include Vijay Shankarlal Bankda (Vincit Biotech International Private Limited), Ankit Jain (Syncom Formulations (India) Limited), Ankit Kedarmal Bankda (Syncom Formulations (India) Limited), Rahul Vijay Bankda (Syncom Formulations (India) Limited), Ritesh Kumar Lunkad (Syncom Formulations (India) Limited), Ruchi Jindal (Syncom Formulations (India) Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available